Learn how weight loss, diet changes and regular exercise can help manage — and sometimes reverse — fatty liver disease when ...

Arrowhead Pharmaceuticals said Tuesday that its gene-silencing candidates helped people with obesity lose fat.

Arrowhead Pharmaceuticals reported early trial data showing notable reductions in body, liver, and visceral fat from two experimental obesity drugs, with more results expected in 2026.

A final option, less commonly used, is a technique called atherectomy. This treatment uses a device that cuts or grinds away the hardened deposition (atheroma) within the artery. Atherectomy is less ...